|
|
| | Acetamide, N-cyclohexyl-2-[(4,5-dihydro-5-methyl-4-oxo-3-phenyl-3H-pyrimido[5,4-b]indol-2-yl)thio]- Basic information |
| | Acetamide, N-cyclohexyl-2-[(4,5-dihydro-5-methyl-4-oxo-3-phenyl-3H-pyrimido[5,4-b]indol-2-yl)thio]- Chemical Properties |
| density | 1.34±0.1 g/cm3(Predicted) | | pka | 14.14±0.20(Predicted) |
| | Acetamide, N-cyclohexyl-2-[(4,5-dihydro-5-methyl-4-oxo-3-phenyl-3H-pyrimido[5,4-b]indol-2-yl)thio]- Usage And Synthesis |
| Uses | 1Z105 is an oral active TLR4/MD2 ligand. 1Z105 enhances dendritic cell maturation and antigen presentation and prevents rthritis[1][2]. | | References | [1] Goff PH, et al. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. J Virol. 2015;89(6):3221-3235. DOI:10.1128/JVI.03337-14 [2] Hayashi T, et al. Novel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammation. J Pharmacol Exp Ther. 2014;350(2):330-340. DOI:10.1124/jpet.114.214312 |
| | Acetamide, N-cyclohexyl-2-[(4,5-dihydro-5-methyl-4-oxo-3-phenyl-3H-pyrimido[5,4-b]indol-2-yl)thio]- Preparation Products And Raw materials |
|